CLINICAL_TRIALS
ClinicalTrials.gov record update
Phase 0 Trial of [F-18]-5-Fluoro-2'-Deoxycytidine With Tetrahydrouridine
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT01479348
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:37:41.947387+00:00
- Published At
- 2020-05-22T00:00:00+00:00
- Record Updated At
- 2020-06-02
- Results Posted At
- 2020-05-22
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Head and Neck Neoplasms", "Lung Neoplasms", "Urinary Bladder Neoplasms", "Breast Neoplasms"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2020-06-02"- protocolSection.identificationModule.nctId
"NCT01479348"- protocolSection.identificationModule.officialTitle
"Phase 0 Trial of [F-18]-5-Fluoro-2\u0027-Deoxycytidine With Tetrahydrouridine"- protocolSection.statusModule.overallStatus
"TERMINATED"- protocolSection.designModule.phases
["EARLY_PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2020-05-22"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.